Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Gene Tien has joined CRA as a vice president ...

These are exciting times for biotech business Complement Therapeutics, which stands on the cusp of an important milestone in ...

Drought- and salt-resistant rice varieties are being developed in India as part of fascinating gene-editing work.

The Donald Trump administration is exerting pressure on India to open up its market to American soyabean and maize, which are ...

As DNA technology continues to evolve, the dream of an insulin-free future for individuals living with Type 1 diabetes is becoming more tangible ...

TWO distinct genetic populations of anopheles mosquitoes with different DNA and resistance levels are scattered across the country, a collaborative study has uncovered. Dr Joel Odero, a senior ...